---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-307964"
form_type: "8-K"
ticker: "KPTI"
cik: "0001503802"
company_name: "Karyopharm Therapeutics Inc."
filed_at: "2026-07-17T21:01:30+00:00"
generated_at: "2026-07-17T21:02:03.935576+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Karyopharm implements 2026 Leadership Cash Retention Program with $3.715M in total awards to four executives

## Summary
- CEO Richard Paulson receives $1.725M; CFO Lori Macomber $625K; CMO Reshma Rangwala $725K; CDO Stuart Poulton $640K.
- Program replaces 2026 Annual Bonus Plan guaranteed amounts; awards are lump sum cash.
- Awards subject to repayment if executive leaves before 12 months or 30 days post-corporate event, unless termination is without cause, good reason, death/disability.
- Retention program aims to incentivize key employees during period of expected catalysts.

## SEC filing metadata
- accession: 0001193125-26-307964
- form_type: 8-K
- ticker: KPTI
- cik: 0001503802
- company_name: Karyopharm Therapeutics Inc.
- filed_at: 2026-07-17T21:01:30+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503802/000119312526307964/0001193125-26-307964-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503802/000119312526307964/d116036d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-307964
- JSON: https://secwatch.observer/filing/0001193125-26-307964.json
- Plain text: https://secwatch.observer/filing/0001193125-26-307964.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.